UWorld USMLE

What is UWorld and who sells it?

UWorld LLC is a private company in Dallas, Texas. The company fact sheet and timeline page say it began as USMLEWorld in 2003 and rebranded as UWorld in 2014, and that founder Chandra Pemmasani, MD, started writing questions in 2001.

On ownership, one business directory (bitscale.ai) lists the company as self-funded. No funding round or acquisition is reported.

The product details below come from the Step 1, Step 2 CK and Step 3 pages on medical.uworld.com.

What does the product include?

Per the Step 1 page, the QBank has more than 3,600 practice questions that students assemble into custom tests. The same page lists UAsk, an AI study assistant the vendor describes as trained on UWorld data, plus more than 500 Medical Videos. The videos are sold in a separate tier called QBank Plus rather than in the base QBank.

UAsk is metered by plan. The Step 2 CK page lists up to 100 prompts on the 30-day plan, up to 250 on the 90-day plan and up to 1,000 on the 180-, 360- and 730-day plans. The Step 1 page lists up to 100 prompts for its packages, which does not match the Step 2 CK figures.

Self-assessment forms are sold separately. Step 2 CK offers forms 1 to 3 at two weeks each, and longer plans bundle two or three of them. UWorld also launched combined USMLE and COMLEX products in 2021, according to a Business Wire release from that year.

No independent test of UAsk's accuracy is published. The vendor's description is the only source for what it does.

What does it do well?

Scope is the clearest strength that can be documented. One vendor covers Step 1, Step 2 CK and Step 3, with fixed access lengths from 30 days to 730 days for the first two. A student who finishes Step 1 and plans Step 2 CK stays inside the same interface and the same account.

Plan design is simple. The access length is the main variable, and the page states what each length includes: self-assessments, a one-time reset, a study planner and the AI prompt allowance. A buyer can read the grid and see what the $579 tier contains compared with the $459 tier.

Reputation rests on one line from a Medscape piece, cited by CB Insights, that called UWorld the go-to study app among the students it consulted (date not stated). No resident reviews are published to set beside it.

Where does it fall short?

Cost per exam is the main objection, and the price structure adds to it. Access is time-boxed. Per the Step 2 CK page, renewals must be bought before expiry, cannot be deferred, and are not offered for expired subscriptions. A student who lets a plan lapse in the final week before the exam cannot extend it at the renewal rate. Step 1 and Step 2 CK extensions list at $49 for 7 days and $139 for 30 days.

There is no trial. The FAQ text on the product pages says the company does not offer guest or trial accounts, and the free option is a sample-question demo even though the page carries "Free Trial" links. Someone who wants to judge the interface and the explanation style before paying has only that demo to go on.

Refunds are narrow. Per the same FAQ, refunds are considered case by case, only for subscriptions longer than 30 days, with a 10 percent processing fee (minimum $10). Self-assessments and Step 3 products are listed as non-refundable, and a package becomes entirely non-refundable once any self-assessment in it is used.

UWorld does not bundle a reference library. A student who wants a searchable library next to the questions has to buy that separately, so the pairing most often discussed is with AMBOSS. A Lecturio blog post (Lecturio sells a competing bank, so weigh it accordingly) puts UWorld plus AMBOSS at roughly $750 a year.

What does it cost?

The headline figure is $579 for a 360-day Step 1 or Step 2 CK QBank, one-time, as of October 2026 per the vendor's product pages. Shorter and longer plans, the Plus tier, Step 3 pricing, renewals and discounts follow in the pricing section. Institutional rates are not public. The only figure is a 2018 Indiana University School of Medicine post saying bulk pricing required more than 50 subscriptions in one order, which is too old to rely on.

How does it compare with the alternatives?

AMBOSS is the closest like-for-like comparison because it also sells a Step 1, Step 2 CK and Step 3 question bank. The structural difference is that AMBOSS is a subscription that bundles a Medical Library, and its question bank is billed on top of the membership, while UWorld sells fixed-length question access with no library. Which model suits a buyer depends on whether they want a reference alongside the questions.

Boards and Beyond, Pathoma and USMLE-Rx sit beside UWorld rather than against it. Boards and Beyond and Pathoma are video-led courses, and USMLE-Rx sells its own Qmax question bank at $299 for 12 months at list price per its pricing page. If the choice is between UWorld and USMLE-Rx Qmax on price alone, USMLE-Rx is cheaper for a year of access, but we have no source comparing the two banks on question quality, so price is the only axis we can state.

What does the evidence say?

Almost nothing exists. No published study ties UWorld use to Step score changes, and claims of the form "N completed questions raise a score by M points" have no published source.

The vendor publishes no HIPAA, SOC 2 or HITRUST attestation, which fits a product that holds no patient data. A residency program licensing seats for staff should ask UWorld how it handles student data, because no published statement exists either way.

Who should buy it, and who should not?

A third-year student with a dedicated Step 2 CK window, at a school that has not negotiated a different bank, should price the 90-day and 180-day tiers against the real study calendar. The arithmetic punishes a short plan that runs over: a 30-day plan at $349 plus one 30-day extension at $139 comes to $488, which is more than the $459 for 90 days outright.

A PGY-1 paying out of pocket for Step 3 faces the same sums with fewer free hours. The Step 3 grid starts at 90 days, so there is no one-month option to fall back on.

A preclinical student in the first year of school gains little from a Step 1 QBank bought early. Access is time-boxed, so buying early spends access time before dedicated study begins.

An AMA member should check the member discount before paying list. The AMA page says up to $69 off Step 1 and Step 2 QBanks and up to $79 off Step 3, with a code-request deadline of 30 November 2026, for new subscriptions only and not combinable with other offers. AMA pages give different end dates, so confirm on the live page.

The verdict

UWorld is the default question bank to price first, and for most candidates the decision is which tier and which length, not whether to look at it. It offers no trial, no library and no published outcome data. Buy it when the study window is fixed and funded, take the longer plan only if the calendar can use it, and remember that an expired plan cannot be extended at the renewal rate.